Andreas Menrad joins Ablynx as CSO
This article was originally published in Scrip
Executive Summary
Belgium's Ablynx has appointed Dr Andreas Menrad, who has over 20 years' experience in the pharmaceutical and biotech industries, chief scientific officer. Dr Menrad previously served at Genzyme for five years, most recently as general manager and vice-president of antibody therapeutics.